InfoBionic

InfoBionic MoMe ARC® from InfoBionic.Ai: an advanced remote cardiac monitoring platform that provides near real-time full disclosure patient data.

InfoBionic.Ai is a digital health company that is dedicated to providing anywhere, anytime access to cardiac arrhythmia monitoring with improved detection and clinical efficacy through a lower cost business model. InfoBionic.Ai’s MoMe ARC® offers superior remote patient monitoring for chronic diseases with an initial market focus on cardiac arrhythmias.

Faster diagnosis. Smarter operations. Healthier outcomes. 🫀📲InfoBionic.Ai delivers near real-time monitoring and AI-powe...
07/23/2025

Faster diagnosis. Smarter operations. Healthier outcomes. 🫀📲

InfoBionic.Ai delivers near real-time monitoring and AI-powered cardiac insights that are built to accelerate care, ease clinical burden, and reduce costly delays across your system.

Ready to make RPM work harder for your organization?

👉 https://infobionic.ai/contact-us/

07/21/2025

🔎 Clinicians today have more cardiac data than ever, but is it helping? 📊 When it comes to remote monitoring, do you feel like you’re getting adequate data?

What kind of data are you getting from your current cardiac monitoring solution?

-Just the right amount
-Too much, poorly filtered
-Not enough context
-Inconsistent quality

Leave your answer in the comments and let us know your thoughts!

What if heart disease could be caught before symptoms even appear? 🫀⚡In PM360, Mark Goddard, VP of Clinical Services at ...
07/16/2025

What if heart disease could be caught before symptoms even appear? 🫀⚡

In PM360, Mark Goddard, VP of Clinical Services at InfoBionic.Ai, explains how AI-powered ECG analysis is changing the game—giving clinicians the insights they need to intervene earlier and avoid costly escalations.

Fewer emergencies. Better outcomes. Smarter care.

📖 Read more: https://www.pm360online.com/ai-update-ai-ecg-remote-monitoring-power-proactive-cardiac-care/

07/07/2025

When it comes to the heart, timing is everything. ⏱️❤️

At what point do you typically intervene after identifying an abnormal rhythm?

-Immediately
-Within 24 hours
-Within the week
-Depends on severity

Comment your answer and let us know your thoughts!

Adult congenital heart disease (ACHD) patients face a silent threat: a lack of data. In our latest post, we explore how ...
07/02/2025

Adult congenital heart disease (ACHD) patients face a silent threat: a lack of data. In our latest post, we explore how AI-enabled remote cardiac monitoring could help bridge the CHD data desert, improving outcomes through smarter, continuous care. 📈 ❤️‍🩹

🔗 Read the full blog: https://infobionic.ai/blog/the-chd-data-desert-how-ai-can-fill-the-gaps/

06/16/2025

🏥⚠️ Workforce strain is real in healthcare. How is your current clinical team handling the volume of cardiac monitoring cases?

-We’re managing
-We’re stretched thin
-Overwhelmed weekly
-Outsourcing where we can

Comment your answer to let us know what your day-to-day looks like.

Address

Waltham, MA

Opening Hours

Monday 9am - 5pm
Tuesday 9am - 5pm
Wednesday 9am - 5pm
Thursday 9am - 5pm
Friday 9am - 5pm

Telephone

+19786748304

Alerts

Be the first to know and let us send you an email when InfoBionic posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to InfoBionic:

Share

Category

Our Story

InfoBionic is a digital health company transforming ambulatory remote patient monitoring processes by optimizing clinical and real-world utility for the users that need it most – physicians and their patients. The Massachusetts-based team of seasoned entrepreneurs have had successful careers in healthcare, IT, medical devices and mobile technology, and bring specific expertise in remote monitoring and cardiology. They have seen first-hand the complexities of traditional cardiac arrhythmia detection and monitoring processes and designed the transformative MoMe® Kardia platform to remove the roadblocks to allow for faster, more effective diagnosis and clinical decision-making. Frost & Sullivan bestowed the 2019 North American Remote Cardiac Monitoring Technology Leadership Award upon InfoBionic. For more information visit www.infobionic.com.